Some liver failure treatment options include reducing your salt intake to avoid complications associated with swelling (ascites). And being prescribed beta-blockers to prevent internal bleeding (haemorrhaging) — works by slowing down your heart.
Micronutrient deficiencies are also a big concern in liver failure. The most common deficiencies are vitamin A, vitamin D, vitamin E, vitamin K, and zinc. These can be treated with increased calorie and protein intake. Or you might need to take them in supplement form depending on how ill you are.
If your liver failure is at an advanced stage, or you develop a serious complication, and other treatments don’t appear to work, a specialist might refer you for a liver transplant.
The best way to prevent chronic liver failure is to slow the damage and scarring of your liver or to prevent developing these conditions altogether.
The good news is that lifestyle changes can reduce your risk of developing many conditions that lead to liver failure. This includes the two most common conditions — NAFLD and ARLD.
Manage your weight
The key lifestyle changes that can prevent NAFLD are weight loss if you’re overweight and managing any metabolic conditions you might have, like type 2 diabetes.
Find out more about weight management.
Follow a Mediterranean diet
The Mediterranean diet is a great way to reduce your risk of insulin resistance. This involves eating a diet rich in vegetables, whole grains, and unsaturated fats. It’s also linked to reducing fatty deposits in your liver associated with NAFLD.
Reduce your alcohol intake
The key lifestyle change for ARLD is reducing how much alcohol you drink. The damage done to your liver increases the more you drink, which is why the current UK guidelines are to consume less than 14 units a week regularly. This equals 6 pints of beer or 10 small glasses of wine.
Anything that affects the health of your liver has the potential to progress the damage, even if it’s not the root cause of that condition. For example, drinking alcohol and obesity can increase the chance of mortality for all types of liver disease. So managing your weight and reducing your alcohol intake to below-recommended limits can help prevent the development of liver failure from multiple causes.
Arroyo, V., Moreau, R., & Jalan, R. (2020). Acute-on-chronic liver failure. New England Journal of Medicine, 382(22), 2137-2145.
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010). Acute liver failure. The Lancet, 376(9736), 190-201
Hajifathalian, K., Torabi Sagvand, B., & McCullough, A. J. (2019). Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study. Hepatology, 70(2), 511-521
Hart, C. L., Morrison, D. S., Batty, G. D., Mitchell, R. J., & Smith, G. D. (2010). Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. Bmj, 340.
Jayalakshmi, Vadivukkarasi T.; Bernal, William Update on the management of acute liver failure, Current Opinion in Critical Care: April 2020 - Volume 26 - Issue 2 - p 163-170 doi: 10.1097/MCC.0000000000000697
Kim, D., Cholankeril, G., Li, A. A., Kim, W., Tighe, S. P., Hameed, B., ... & Ahmed, A. (2019). Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014. Liver International, 39(9), 1661-1671.
Lee, W. M., Hynan, L. S., Rossaro, L., Fontana, R. J., Stravitz, R. T., Larson, A. M., ... & Acute Liver Failure Study Group. (2009). Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology, 137(3), 856-864.
Liou, I. W. (2014). Management of end-stage liver disease. Medical Clinics, 98(1), 119-152.
Peng, J. K., Hepgul, N., Higginson, I. J., & Gao, W. (2019). Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliative medicine, 33(1), 24-36.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 38(2), 485-521.
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., ... & Wilson, A. M. (2013). The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Journal of hepatology, 59(1), 138-143.
Sheron, N. (2016). Alcohol and liver disease in Europe–Simple measures have the potential to prevent tens of thousands of premature deaths. Journal of Hepatology, 64(4), 957-967.
Thoma, C., Day, C. P., & Trenell, M. I. (2012). Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. Journal of hepatology, 56(1), 255-266
UK Chief Medical Officers. (2016). UK Chief Medical Officers’ Low Risk Drinking Guidelines. Retrieved 2 December 2021 from https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/545937/UK_CMOs__report.pdf